# Study the Effect of Avanafil on the Pharmacodynamics and Pharmacokinetics of Warfarin in Healthy Male Subjects

> **NCT01095588** · PHASE1 · COMPLETED · sponsor: **VIVUS LLC** · enrollment: 24 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** 200 mg Avanafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01095588
- **Lead sponsor:** VIVUS LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2011-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01095588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01095588, "Study the Effect of Avanafil on the Pharmacodynamics and Pharmacokinetics of Warfarin in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01095588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*